Cargando…
Clinical Features and Prognostic Factors for Primary Anaplastic Large Cell Lymphoma of the Central Nervous System: A Systematic Review
SIMPLE SUMMARY: Primary anaplastic large cell lymphoma (ALCL) of the central nervous system (CNS) is a subtype of primary central nervous system lymphoma (PCNSL). ALCL is divided into anaplastic lymphoma kinase (ALK)-positive ALCL and ALK-negative ALCL, according to ALK expression. ALK-positive canc...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431692/ https://www.ncbi.nlm.nih.gov/pubmed/34503168 http://dx.doi.org/10.3390/cancers13174358 |
_version_ | 1783750997270593536 |
---|---|
author | Hirano, Yudai Miyawaki, Satoru Tanaka, Shota Taoka, Kazuki Hongo, Hiroki Teranishi, Yu Takami, Hirokazu Takayanagi, Shunsaku Kurokawa, Mineo Saito, Nobuhito |
author_facet | Hirano, Yudai Miyawaki, Satoru Tanaka, Shota Taoka, Kazuki Hongo, Hiroki Teranishi, Yu Takami, Hirokazu Takayanagi, Shunsaku Kurokawa, Mineo Saito, Nobuhito |
author_sort | Hirano, Yudai |
collection | PubMed |
description | SIMPLE SUMMARY: Primary anaplastic large cell lymphoma (ALCL) of the central nervous system (CNS) is a subtype of primary central nervous system lymphoma (PCNSL). ALCL is divided into anaplastic lymphoma kinase (ALK)-positive ALCL and ALK-negative ALCL, according to ALK expression. ALK-positive cancers tend to develop at a younger age and tend to have a better prognosis. Almost all past articles on primary ALCL of the CNS have been case reports and there have been no randomized trials or cohort studies on this subject. We thus performed a systematic review of primary ALCL of the CNS. According to the author’s survey, 36 case reports have been published in English-language journals. In this paper, we have summarized the clinical features and prognostic factors for primary ALCL of the CNS based on previous studies. ABSTRACT: Primary anaplastic large cell lymphoma (ALCL) of the central nervous system (CNS) is a subtype of primary CNS lymphoma (PCNSL). There are very few comprehensive reports on this extremely rare tumor. Therefore, it is necessary to investigate the clinical features and prognostic factors for primary ALCL of the CNS. We performed a systematic review of the published literature. Past cases were comprehensively searched using PubMed, Cochrane Library, and Web of Science. Clinical information, such as age, sex, anaplastic lymphoma kinase (ALK) status, lesion sites, treatment methods, and survivorship were extracted. Thirty-nine cases with information on ALK status and treatment course were identified. The average observation period was 13 months, and the overall 2-year survival rate was 58%. Univariate analyses showed a statistically significantly better prognosis among patients < 40 years of age (p = 0.039, HR 0.32 (0.11–0.95)) and in relation to ALK positivity (p = 0.010, HR 0.24 (0.08–0.71) and methotrexate treatment (p = 0.003, HR 0.17 (0.05–0.56)). Because of the sparsity of cases, it is necessary to accumulate cases in order to perform more detailed analyses. |
format | Online Article Text |
id | pubmed-8431692 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84316922021-09-11 Clinical Features and Prognostic Factors for Primary Anaplastic Large Cell Lymphoma of the Central Nervous System: A Systematic Review Hirano, Yudai Miyawaki, Satoru Tanaka, Shota Taoka, Kazuki Hongo, Hiroki Teranishi, Yu Takami, Hirokazu Takayanagi, Shunsaku Kurokawa, Mineo Saito, Nobuhito Cancers (Basel) Systematic Review SIMPLE SUMMARY: Primary anaplastic large cell lymphoma (ALCL) of the central nervous system (CNS) is a subtype of primary central nervous system lymphoma (PCNSL). ALCL is divided into anaplastic lymphoma kinase (ALK)-positive ALCL and ALK-negative ALCL, according to ALK expression. ALK-positive cancers tend to develop at a younger age and tend to have a better prognosis. Almost all past articles on primary ALCL of the CNS have been case reports and there have been no randomized trials or cohort studies on this subject. We thus performed a systematic review of primary ALCL of the CNS. According to the author’s survey, 36 case reports have been published in English-language journals. In this paper, we have summarized the clinical features and prognostic factors for primary ALCL of the CNS based on previous studies. ABSTRACT: Primary anaplastic large cell lymphoma (ALCL) of the central nervous system (CNS) is a subtype of primary CNS lymphoma (PCNSL). There are very few comprehensive reports on this extremely rare tumor. Therefore, it is necessary to investigate the clinical features and prognostic factors for primary ALCL of the CNS. We performed a systematic review of the published literature. Past cases were comprehensively searched using PubMed, Cochrane Library, and Web of Science. Clinical information, such as age, sex, anaplastic lymphoma kinase (ALK) status, lesion sites, treatment methods, and survivorship were extracted. Thirty-nine cases with information on ALK status and treatment course were identified. The average observation period was 13 months, and the overall 2-year survival rate was 58%. Univariate analyses showed a statistically significantly better prognosis among patients < 40 years of age (p = 0.039, HR 0.32 (0.11–0.95)) and in relation to ALK positivity (p = 0.010, HR 0.24 (0.08–0.71) and methotrexate treatment (p = 0.003, HR 0.17 (0.05–0.56)). Because of the sparsity of cases, it is necessary to accumulate cases in order to perform more detailed analyses. MDPI 2021-08-28 /pmc/articles/PMC8431692/ /pubmed/34503168 http://dx.doi.org/10.3390/cancers13174358 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Systematic Review Hirano, Yudai Miyawaki, Satoru Tanaka, Shota Taoka, Kazuki Hongo, Hiroki Teranishi, Yu Takami, Hirokazu Takayanagi, Shunsaku Kurokawa, Mineo Saito, Nobuhito Clinical Features and Prognostic Factors for Primary Anaplastic Large Cell Lymphoma of the Central Nervous System: A Systematic Review |
title | Clinical Features and Prognostic Factors for Primary Anaplastic Large Cell Lymphoma of the Central Nervous System: A Systematic Review |
title_full | Clinical Features and Prognostic Factors for Primary Anaplastic Large Cell Lymphoma of the Central Nervous System: A Systematic Review |
title_fullStr | Clinical Features and Prognostic Factors for Primary Anaplastic Large Cell Lymphoma of the Central Nervous System: A Systematic Review |
title_full_unstemmed | Clinical Features and Prognostic Factors for Primary Anaplastic Large Cell Lymphoma of the Central Nervous System: A Systematic Review |
title_short | Clinical Features and Prognostic Factors for Primary Anaplastic Large Cell Lymphoma of the Central Nervous System: A Systematic Review |
title_sort | clinical features and prognostic factors for primary anaplastic large cell lymphoma of the central nervous system: a systematic review |
topic | Systematic Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431692/ https://www.ncbi.nlm.nih.gov/pubmed/34503168 http://dx.doi.org/10.3390/cancers13174358 |
work_keys_str_mv | AT hiranoyudai clinicalfeaturesandprognosticfactorsforprimaryanaplasticlargecelllymphomaofthecentralnervoussystemasystematicreview AT miyawakisatoru clinicalfeaturesandprognosticfactorsforprimaryanaplasticlargecelllymphomaofthecentralnervoussystemasystematicreview AT tanakashota clinicalfeaturesandprognosticfactorsforprimaryanaplasticlargecelllymphomaofthecentralnervoussystemasystematicreview AT taokakazuki clinicalfeaturesandprognosticfactorsforprimaryanaplasticlargecelllymphomaofthecentralnervoussystemasystematicreview AT hongohiroki clinicalfeaturesandprognosticfactorsforprimaryanaplasticlargecelllymphomaofthecentralnervoussystemasystematicreview AT teranishiyu clinicalfeaturesandprognosticfactorsforprimaryanaplasticlargecelllymphomaofthecentralnervoussystemasystematicreview AT takamihirokazu clinicalfeaturesandprognosticfactorsforprimaryanaplasticlargecelllymphomaofthecentralnervoussystemasystematicreview AT takayanagishunsaku clinicalfeaturesandprognosticfactorsforprimaryanaplasticlargecelllymphomaofthecentralnervoussystemasystematicreview AT kurokawamineo clinicalfeaturesandprognosticfactorsforprimaryanaplasticlargecelllymphomaofthecentralnervoussystemasystematicreview AT saitonobuhito clinicalfeaturesandprognosticfactorsforprimaryanaplasticlargecelllymphomaofthecentralnervoussystemasystematicreview |